PO-16 - ASK1 regulates tumor lung metastasis and platelet functions

M Kamiyama1, I Naguro1, H Ichijo1

  • 1Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

Thrombosis Research
|May 11, 2016
PubMed
Abstract

Insights

Apoptosis signal-regulating kinase 1 (ASK1) deficiency impairs platelet function, reducing early-stage lung metastasis in mice. This suggests ASK1 plays a key role in platelet-mediated tumor cell spread.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Apoptosis signal-regulating kinase 1 (ASK1) is a MAP3K involved in stress responses and tumorigenesis.
  • ASK1's role in tumor metastasis remains largely unexplored.
  • This study investigates ASK1's function in the context of cancer metastasis.

Purpose of the Study:

  • To elucidate the role of ASK1 in tumor metastasis.
  • To determine if ASK1 influences early-stage lung metastasis.
  • To examine the impact of ASK1 deficiency on platelet function in metastasis.

Main Methods:

  • An experimental lung metastasis model using Lewis lung carcinoma cells (3LL-Luc2) in mice.
  • Assessment of lung metastasis via luciferase activity measurement.
  • Analysis of platelet function using tail bleeding and ferric chloride-induced thrombosis models.

Main Results:

  • ASK1 knockout (ASK1-/-) mice exhibited significantly reduced lung metastasis compared to wild-type (WT) mice.
  • ASK1 deficiency impaired platelet aggregation and response to agonists.
  • ASK1-/- mice displayed bleeding tendencies and defective thrombosis, indicating altered platelet function.

Conclusions:

  • ASK1 is crucial for early-stage tumor lung metastasis.
  • Impaired platelet function due to ASK1 deficiency attenuates tumor metastasis.
  • Targeting ASK1 in platelets could be a therapeutic strategy for reducing metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.5K